Sb Center Research Articles

Carbodicarbene‐Stibenium Ion‐Mediated Functionalization of C(sp3)−H and C(sp)−H Bonds

AbstractMain‐group element‐mediated C−H activation remains experimentally challenging and the development of clear concepts and design principles has been limited by the increased reactivity of relevant complexes, especially for the heavier elements. Herein, we report that the stibenium ion [(pyCDC)Sb][NTf2]3 (1) (pyCDC=bis‐pyridyl carbodicarbene; NTf2=bis(trifluoromethanesulfonyl)imide) reacts with acetonitrile in the presence of the base 2,6‐di‐tert‐butylpyridine to enable C(sp3)−H bond breaking to generate the stiba‐methylene nitrile complex [(pyCDC)Sb(CH2CN)][NTf2]2 (2). Kinetic analyses were performed to elucidate the rate dependence for all the substrates involved in the reaction. Computational studies suggest that C−H activation proceeds via a mechanism in which acetonitrile first coordinates to the Sb center through the nitrogen atom in a κ1 fashion, thereby weakening the C−H bond which can then be deprotonated by base in solution. Further, we show that 1 reacts with terminal alkynes in the presence of 2,6‐di‐tert‐butylpyridine to enable C(sp)−H bond breaking to form stiba‐alkynyl adducts of the type [(pyCDC)Sb(CCR)][NTf2]2 (3 a–f). Compound 1 shows excellent specificity for the activation of the terminal C(sp)−H bond even across alkynes with diverse functionality. The resulting stiba‐methylene nitrile and stiba‐alkynyl adducts react with elemental iodine (I2) to produce iodoacetonitrile and iodoalkynes, while regenerating an Sb trication.

Carbodicarbene-Stibenium Ion-Mediated Functionalization of C(sp3)-H and C(sp)-H Bonds.

Main-group element-mediated C-H activation remains experimentally challenging and the development of clear concepts and design principles has been limited by the increased reactivity of relevant complexes, especially for the heavier elements. Herein, we report that the stibenium ion [(pyCDC)Sb][NTf2]3 (1) (pyCDC=bis-pyridyl carbodicarbene; NTf2=bis(trifluoromethanesulfonyl)imide) reacts with acetonitrile in the presence of the base 2,6-di-tert-butylpyridine to enable C(sp3)-H bond breaking to generate the stiba-methylene nitrile complex [(pyCDC)Sb(CH2CN)][NTf2]2 (2). Kinetic analyses were performed to elucidate the rate dependence for all the substrates involved in the reaction. Computational studies suggest that C-H activation proceeds via a mechanism in which acetonitrile first coordinates to the Sb center through the nitrogen atom in a κ1 fashion, thereby weakening the C-H bond which can then be deprotonated by base in solution. Further, we show that 1 reacts with terminal alkynes in the presence of 2,6-di-tert-butylpyridine to enable C(sp)-H bond breaking to form stiba-alkynyl adducts of the type [(pyCDC)Sb(CCR)][NTf2]2 (3 a-f). Compound 1 shows excellent specificity for the activation of the terminal C(sp)-H bond even across alkynes with diverse functionality. The resulting stiba-methylene nitrile and stiba-alkynyl adducts react with elemental iodine (I2) to produce iodoacetonitrile and iodoalkynes, while regenerating an Sb trication.

Pnictogen-Bonding Enzymes.

The objective of this study was to create artificial enzymes that capitalize on pnictogen bonding, a σ-hole interaction that is essentially absent in biocatalysis. For this purpose, stibine catalysts were equipped with a biotin derivative and combined with streptavidin mutants to identify an efficient transfer hydrogenation catalyst for the reduction of a fluorogenic quinoline substrate. Increased catalytic activity from wild-type streptavidin to the best mutants coincides with the depth of the σ hole on the Sb(V) center, and the emergence of saturation kinetic behavior. Michaelis-Menten analysis reveals transition-state recognition in the low micromolar range, more than three orders of magnitude stronger than the millimolar substrate recognition. Carboxylates preferred by the best mutants contribute to transition-state recognition by hydrogen-bonded ion pairing and anion-π interactions with the emerging pyridinium product. The emergence of challenging stereoselectivity in aqueous systems further emphasizes compatibility of pnictogen bonding with higher order systems catalysis.

Tri-aryl antimony(V) hydroximato and hydroxamato complexes: Combining lipophilic Sb(III/V) and hydroxamic acids in combating Leishmania

Six novel tri-aryl antimony(V) hydroximato complexes (3–8) with composition [SbAr3(O2NCR)] (3: Ar = Ph, R = o-(OH)Ph, 4: Ar = Ph, R = Me, 5: Ar = Ph, R = Ph; 6: Ar = Mes, R = Me, 7: Ar = Mes, R = Ph, 8: Ar = Mes, R = o-(OH)Ph (where Ph = phenyl, Me = methyl, Mes = mesityl)), were synthesised and evaluated for anti-parasitic activity towards Leishmania major (L. major) promastigotes and amastigotes. Complexes of the form [SbAr3(O2NCR)], with the dianionic hydroximato ligand binding O,O′-bidentate to the Sb(V) centre, exist in the solid-state for the mesityl-derived complexes. In contrast, the phenyl-ligated Sb(V) complexes crystallise as the hexacoordinate, hydroxamato species [SbPh3(O2NHC(OH))], with the OH ligand derived from entrained H2O in the crystallisation solvent. It is found that both the aryl and hydroximato ligands are found to influence the bioactivity of the Sb(V) complexes. Complexes 3–8 exhibited varied anti-promastigote activity with IC50 values ranging from 1.53 μM for 6 to 36.0 μM for 3, also reflected in varied anti-amastigote activity with a percentage infection range of 5.50% for 6 to 29.00% for 3 at a concentration of 10 μM. The complexes were relatively non-toxic to human fibroblasts with an IC50 value range of 59.3 μM (7) to ≥100 μM (3–6, 8), and exhibited varied toxicity towards J774.1 A macrophages (IC50: 3.97 (6) to ≥100 (8) μM). All complexes showed enhanced activity compared to the parent hydroxamic acids.

Incorporation of Antimony Ions in Heptaisobutyl Polyhedral Oligomeric Silsesquioxanes

The direct incorporation of Sb(V) ions into a polycondensed silsesquioxane network based on heptaisobutyl POSS units (Sb(V)-POSSs) through a corner-capping reaction is reported for the first time in this work. As a reference sample, a completely condensed monomeric Sb(III)-POSS was prepared using a similar synthetic protocol. The chemical properties of both Sb-containing POSSs were investigated with different analytical and spectroscopic techniques. The analyses confirm the success of the corner-capping reaction for both samples and indicate that an Sb(V)-POSS sample is characterized by a heterogenous multimeric arrangement with an irregular organization of POSS cages linked to Sb(V) centers, and has a more complex structure with respect to the well-defined monomeric Sb(III)-POSS.

Models of the putative antimony(V)-diolate motifs in antileishmanial pentavalent antimonial drugs.

The structures of the pentavalent antimonials, small-molecule Sb-containing drugs used to treat the neglected tropical disease leishmaniasis, remain unknown despite their widespread use for over half a century. These drugs are prepared by combination of an Sb(V) precursor and a sugar derivative and proposed structures frequently invoke a cyclic stiborane motif in which a vicinal diolate ligand chelates an Sb(V) center. As a step towards better understanding the structures of the pentavalent antimonial drugs, a series of cyclic organostiboranes spanning the stereochemical space afforded by a vicinal diolate motif has been synthesized and characterized. X-ray crystallography and NMR spectroscopy provide unambiguous characterization of the structures of these model compounds and of the interaction of the diolate with the Sb(V) center. Particularly notable are the systematic trends observed in the NMR spectroscopic signals as a function of the stereochemistry of the diolate. The spectroscopic signatures identified with these model compounds will provide a framework for elucidating the structures of the pentavalent antimonial drugs.

Zero-dimensional antimony(III) halides templated by ruthenium complexes: photoluminescence, thermochromism and photo/electrical performances

Zero dimensional antimony(III) halides have captured more and more attention as broadband emitters. Herein, Using photochemically active ruthenium complexes as templates, two new antimony(III) halide based hybrids have been prepared and structurally determined, i.e., [Ru(bipy)3](Sb2Cl6O) (1) and [Ru(phen)3](SbI5) (2). Both the (Sb2Cl6O)2- and (SbI5)2-are rare examples of antimony halides, in which Sb centers are in square pyramidal environments with stereochemically active lone pairs. The (Sb2Cl6O)2- ion bearing secondary Sb···Cl interactions are further stabilized by C-H···Cl hydrogen bonds to give a quasi-3D network. The (SbI5)2- anions are anchored in the 1D[Ru(phen)3]n 2n+ chains based on strong π···π stacking interactions among phenanthroline ligands, which are the reason for the formation of its square pyramid geometry.1 exhibits bright red luminescence but 2produces weak blue emission. This trend might be assigned to the larger conjugated system of phenanthroline in 2, which is dominant by ruling out the contribution of antimony(III) halide. Besides, reversible thermochromism can be found in 1. Furthermore, good electrical chemical and photocurrent performance can be detected. The photoluminescence modulation by controlling the conjugated degree of organic ligands is an efficient strategy for the precise preparation of new luminescent materials.

Methanol-induced luminescence vapochromism based on a Sb3+-doped organic indium halide hybrid

Ion doping has been demonstrated as a practical approach to achieving highly efficient luminescence in both inorganic phosphors and organic-inorganic hybrids. The as-formed doping species show great potential in optoelectronic applications due to their high photoluminescence quantum yield (PLQY) and excellent stability. Herein, we report highly emissive Sb3+-doped indium halides (C6H18N2)InCl5·H2O:Sb (C6H18N22+ = N,N,N′,N′-tetramethylethane-1,2-diammonium) prepared by solution evaporation methods with an emission that peaked at 565 nm and a PLQY of 74.6%. Photophysical characterizations and density functional theory computational studies verify the broadband emission originating from a self-trapped exciton. Interestingly, a drastic red shift of the emission peak from 565 to 663 nm with yellow luminescence turning to red is observed once the (C6H18N2)InCl5·H2O:Sb hybrid is exposed to methanol vapor. Moreover, when the methanol-exposed hybrid is put in air, the emission reverts to 565 nm in several minutes. Single-crystal X-ray diffraction studies show a subsequent structure distortion upon the coordination of methanol to the Sb(III) center, which is responsible for the drastic red shift of the emission. Encouragingly, we found that (C6H18N2)InCl5·H2O:Sb exhibits a specific response to methanol vapor after screening a series of volatile organic compounds with different polarities. Besides, a negligible change of the emission intensity is observed after several cycles of uptaking and releasing methanol. The high fatigue resistance and specific solvent response of the Sb3+-doped indium halide make it a very promising methanol detector.

Lessons learned from FeSb2O4 on stereoactive lone pairs as a design principle for anion insertion

Fluoride-ion batteries are an attractive energy storage concept analogous to lithium-ion batteries but feature an inverted paradigm where anions are the principal charge carriers. Insertion hosts that can reversibly insert fluoride ions at room temperature are exceedingly sparse. Here, we report that topochemical insertion of fluoride ions in FeSb 2 O 4 involves Fe 2+ /Fe 3+ redox but is mediated by multi-center synergies between iron and antimony centers. Separation of the redox center from the p-block coordination site alleviates structural strain by enabling compensatory contraction and expansion of FeO 6 and SbO 3 polyhedra, respectively. p-block electron lone pairs play a critical role in weakening anion-lattice interactions, enabling reversible fluoride-ion diffusion across microns. The results illuminate the key principle that interactions traceable to stereoactive lone pairs can be used to mediate anion-lattice interactions and suggest that anion insertion hosts can be designed by pairing redox-active transition metals with p-block cations bearing stereochemically active electron lone pairs. Topochemical insertion of fluoride ions is mediated by synergies between Fe and Sb centers p-block electron lone pairs weaken anion-lattice interactions X-ray ptychography imaging demonstrates bulk fluoride-ion diffusion Sb 5 s 2 electron lone pairs enable fluoride-ion deinsertion and facile diffusion Despite several decades of research, fundamental design principles for anion insertion in crystalline lattices remain poorly explored. Zaheer et al. provide a fundamental design principle based on electronic structure considerations that allows use of anions (fluoride ions) instead of cations for electrochemical energy storage.

Development of new combination anti-leishmanial complexes: Triphenyl Sb(V) mono-hydroxy mono-quinolinolates

In seeking to develop single entity combination anti-Leishmanial complexes six heteropletic organometallic Sb(V) hydroxido quinolinolate complexes of general formula [SbPh3(C9H4NORR’)(OH)] have been synthesised and characterised, derived from a series of halide substituted quinolinols (8-hydroxyquinolines). Single crystal X-ray diffraction on all the complexes show a common distorted six-coordinate octahedral environment at the Sb(V) centre, with the aryl groups and nitrogen atom of quinolinolate ligand bonding in the equatorial planes, with the two oxygen atoms (hydroxyl and quinolinolate) occupying the axial plane in an almost linear configuration. Each complex was tested for their anti-promastigote activity and mammalian cytotoxicity and a selectivity indices established. The complexes displayed excellent anti-promastigote activity (IC50: 2.03–3.39 μM) and varied mammalian cytotoxicity (IC50: 12.7–46.9 μM), leading to a selectivity index range of 4.52–16.7. All complexes displayed excellent anti-amastigote activity with a percentage infection range of 2.25%–9.00%. All complexes performed substantially better than the parent quinolinols and comparable carboxylate complexes [SbPh3(O2CRR’)2] indicating the synergistic role of the Sb(V) and quinolinol moieties in increasing parasite mortality. Two of the complexes [SbPh3(C9H4NOBr2)(OH)] 4, [SbPh3(C9H4NOI2)(OH)] 5, provide an ideal combination of high selective and good activity towards the leishmanial amastigotes and offer the potential as good lead compounds.

Low-Valent, Multiply Bonded, Trigonal-Planar Sb Complex: Rational Syntheses, Dual Acidic/Basic Properties, and Unexpected Semiconducting Characteristics.

A 4-center, 6π-conjugated, multiply bonded trigonal-planar complex, [Sb{Cr(CO)5}3]- (1), was synthesized via the hydride abstraction of [HSb{Cr(CO)5}3]2- (1-H) with HBF4·H2O, with the release of high yields of H2. The oxidation state of the Sb atom in [Et4N][1] was well-defined as 0, which was evidenced by X-ray photoelectron spectroscopy and X-ray absorption near-edge structure. The distinct color-structure relationship of this low-valent Sb complex 1 toward a wide range of organic solvents was demonstrated, as interpreted by time-dependent density functional theory calculations, allowing the trigonal-planar 1 and the tetrahedral solvent adducts to be probed, revealing the dual acid/base properties of the Sb center. In addition, 1 showed pronounced electrophilicity toward anionic and neutral nucleophiles, even with solvent molecules, to produce tetrahedral complexes [(Nu)Sb{Cr(CO)5}3]n- [1-Nu; n = 2, Nu = H, F, Cl, Br, I, OH; n = 1, Nu = PEt3, PPh3, N,N-dimethylformamide (DMF), acetonitrile (MeCN)]. On the contrary, the Fe/Cr hydride complex [HSb{Fe(CO)4}{Cr(CO)5}2]2- (2-H) was obtained by treating 1 with [HFe(CO)4]-. Upon hydride abstraction of 2-H with HBF4·H2O or [CPh3][BF4], a multiply bonded Fe/Cr trigonal-planar complex, [Sb{Fe(CO)4}{Cr(CO)5}2]- (2), was produced in which the oxidation coupling Sb2-containing complexes [Sb2Cr4Fe2(CO)28]2- (3-Cr) and [HSb2Cr3Fe2(CO)23]- (3-H) were yielded as final products. Complex 3-Cr exhibited dual Lewis acid/base properties via hydridation and protonation reactions, to form 2-H or 3-H, respectively. Surprisingly, [Et4N][1] possessed a low energy gap of 1.13 eV with an electrical conductivity in the range of (1.10-2.77) × 10-6 S·cm-1, showing that [Et4N][1] was a low-energy-gap semiconductor. The crystal packing, crystal indexing, and density of states results of [Et4N][1] further confirmed the efficient through-space conduction pathway via the intermolecular Sb···O(carbonyl) and O(carbonyl)···O(carbonyl) interactions of the 1D anionic zigzag chain of 1.

A Janus antimony sulfide catalyst for highly selective N2 electroreduction.

The antimony sulfide Sb2S3 is firstly explored as a Janus catalyst for highly selective nitrogen reduction reaction (NRR). The developed Sb2S3 nanoflowers delivered an excellent faradaic efficiency of 24.1% and a high NH3 yield of 33.4 μg h-1 mg-1 at -0.3 V. Theoretical calculations revealed that the high NRR selectivity of Sb2S3 originated from the Janus role of active Sb centers: on one hand, Sb exhibited a strong Sb5p-N2p hybridization upon initial N2 protonation, capable of effectively activating the NRR with a low reaction barrier. On the other hand, Sb could concurrently impede the hydrogen evolution by hindering the H+ adsorption.

Triple-Pnictogen Bonding as a Tool for Supramolecular Assembly.

Supramolecular assembly utilizing simultaneous formation of three pnictogen bonds around a single antimony vertex was explored via X-ray crystallography, solution NMR, and computational chemistry. An arylethynyl (AE) ligand was designed to complement the three electrophilic regions around the Sb compound. Though solution studies reveal large binding constants for individual pyridyl units with the Sb donor, the rigidity and prearrangement of the AE acceptor proved necessary to achieve simultaneous binding of three acceptors to the Sb-centered pnictogen-bond donor. Calculations and X-ray structures suggest that negative cooperativity upon sequential binding of three acceptors to a Sb center limits the utility of triple-pnictogen bonding pyridyl acceptors. These limitations can be negated, however, when positive cooperativity is designed into a complementary acceptor ligand.

A Five-Membered PdSbn Coordination Series

Five complexes of the general formula PdCl2(SbMe2Cl)n (n = 1–5) have been synthesized by combining [PdCl2(MeCN)2] and SbMe2Cl in different molar ratios in toluene. Their solid-state structures have been determined by X-ray crystallography. The complexes display considerable structural diversity: [Pd4Cl8(SbMe2Cl)4] (1, n = 1) is a chloride-bridged tetramer; [Pd2Cl4(SbMe2Cl)4] (2, n = 2) is a dimer; [PdCl(SbMe2Cl)2(SbMe2Cl2)] (3, n = 3) is a supramolecular polymer; [Pd2(SbMe2Cl)8]Cl4 (4, n = 4) is a loosely associated dimer, and [Pd(SbMe2Cl)5]Cl2 (5, n = 5) is a monomer with square-pyramidal PdSb5 coordination geometry. Each structure contains secondary interactions between coordinated Sb centers and chloride ligands or anions, resulting in five-coordinate Sb in all cases with a range of Sb···Cl bond lengths. The electronic structures of these complexes have been investigated using DFT methods including NBO and Pipek–Mezey localized orbital methods in order to interrogate both the Sb–Pd and secondary Sb···C...

Tris(benzoimidazol)amine (L) complexes of pnictogen(iii) and pnictogen(v) cations and assessment of the [LP]3+/[LPF2]3+ redox couple.

A series of cationic complexes involving a pnictogen(iii) (Pn = P, As, Sb) centre and the tetradentate ligand tris((1-ethyl-benzoimidazol-2-yl)methyl)amine (BIMEt3) have been synthesized and comprehensively characterized. Oxidation of [P(BIMEt3)]3+ with XeF2 provides access to [PF2(BIMEt3)]3+ representing the first structurally characterized example of a phosphorus(v) centred trication.

Novel antimony(iii) hydroxamic acid complexes as potential anti-leishmanial agents.

Reaction of benzohydroxamic acid (Bha), 2-pyridinehydroxamic acid (2-pyha), 2-amino-phenylhydroxamic acid (2-NH2-pha) and salicylhydroxamic acid (Sha) with SbCl3 in ethanol gave the corresponding novel hydroxamato Sb(iii) complexes, [Sb(Bha-1H)2Cl] 1, [SbCl2(2-pyha-1H)] 2, [Sb(2-NH2-pha-1H)(2-NH3-pha-1H)]Cl23 and [SbCl(Sha-1H)2] 4. In all cases the hydroxamic acids coordinate to the Sb centres in the typical bidentate hydroxamato (O,O') coordination mode, via the carbonyl oxygen and deprotonated hydroxyl group. Reaction of the histone deacetylase inhibitor (HDACi) suberoylanilidehydroxamic acid (SAHA) with Sb(OEt)3 gave the Sb(iii) hydroxamato/hydroximato complex, [Sb(SAHA-1H)(SAHA-2H)] 6. All test complexes significantly inhibited the promastigote proliferation of Leishmania amazonensis and L. chagasi and induced substantial changes in the general morphology of the parasites, including reduction in size and loss of flagellum, when compared to the untreated promastigotes. A dose-response approach using the test complexes showed a decreased in plasma membrane permeability and the mitochondrial dehydrogenase activities of the Leishmania species. [Sb(Bha-1H)2Cl] exhibited the best activity and was superior to the Sb HDACi complex 6. Though 1 exhibited noteworthy anti-leishmanial activity, the selectivity indexes determined suggest that [Sb(2-NH2-pha-1H)(2-NH3-pha-1H)]Cl23 is the test complex that merits further investigation as a potential anti-leishmanial agent.

Structural elucidation and bioassays of newly synthesized pentavalent antimony complexes

Antimony (V) organometallics (1–5) have been synthesized with general formula [SbR′3(O2CR)2], where R' = phenyl, p-tolyl and O2CR are substituted cinnamates. These complexes have been characterized by FT-IR analysis, multinuclear (1H, 13C) NMR spectroscopy and single crystal X-ray diffraction analysis. The crystal structures of [Sb(phenyl)3(4-ClC6H4C2H2O2C)2] (1) and [Sb(p-tol)3(4-OCH3C6H4C2H2O2C)2].CHCl3 (5) displayed distorted geometry between trigonal bipyramidal and square pyramidal with monomeric structure at a five coordinated Sb center. Starting reagents and complexes were evaluated for anticancer, antileishmanial, antibacterial and alpha amylase inhibition potentials. It was observed that complexes 3, 4 and 5 showed significant (p < 0.05) antileishmanial and anticancer activities against Leishmania tropica KWH23 promastigotes and HepG2 cell lines respectively. Antibacterial activity of compound 3 was also significant against E. coli (MIC: 5.55 μg/mL), K. pneumoniae (MIC: 16.66 μg/mL), S. aureus (MIC: 5.55 μg/mL) and P. aeruginosa (MIC: 50 μg/mL). Hence, these new antimony complexes can act as good drug candidates.

Antimony Complexes for Electrocatalysis: Activity of a Main-Group Element in Proton Reduction.

Main-group complexes are shown to be viable electrocatalysts for the H2 -evolution reaction (HER) from acid. A series of antimony porphyrins with varying axial ligands were synthesized for electrocatalysis applications. The proton-reduction catalytic properties of TPSb(OH)2 (TP=5,10,15,20-tetra(p-tolyl)porphyrin) with two axial hydroxy ligands were studied in detail, demonstrating catalytic H2 production. Experiments, in conjunction with quantum chemistry calculations, show that the catalytic cycle is driven via the redox activity of both the porphyrin ligand and the Sb center. This study brings insight into main group catalysis and the role of redox-active ligands during catalysis.

Antimony Complexes for Electrocatalysis: Activity of a Main‐Group Element in Proton Reduction

AbstractMain‐group complexes are shown to be viable electrocatalysts for the H2‐evolution reaction (HER) from acid. A series of antimony porphyrins with varying axial ligands were synthesized for electrocatalysis applications. The proton‐reduction catalytic properties of TPSb(OH)2 (TP=5,10,15,20‐tetra(p‐tolyl)porphyrin) with two axial hydroxy ligands were studied in detail, demonstrating catalytic H2 production. Experiments, in conjunction with quantum chemistry calculations, show that the catalytic cycle is driven via the redox activity of both the porphyrin ligand and the Sb center. This study brings insight into main group catalysis and the role of redox‐active ligands during catalysis.

Synthesis, characterization and antileishmanial studies of some bioactive heteroleptic pentavalent antimonials

In pursuit of safe drug candidates for the treatment of parasitic diseases like leishmaniasis, a series of heteroleptic pentavalent antimonials of the type [R3Sb(O2CR′)2] (1–9) have been synthesized and characterized using elemental analysis (CHN), Fourier transform infrared spectroscopy and multinuclear (1H and 13C) NMR spectroscopy. The carboxylates studied are predominantly substituted benzoates with some complexes having acetato or nicotinato ligands. The crystal structures of [Sb(C6H5)3(o‐NH2C6H4COO)2] (1) and [Sb(C6H5)3(3,5‐Cl2C6H3COO)2] (4) were determined as essentially monomeric with an Sb(V) centre and shown to adopt geometries intermediate between trigonal bipyramidal and square pyramidal. The antileishmanial activity was assessed against Leishmania tropica KWH23, and also human macrophages were used to measure the cytotoxicity of these complexes. The IC50 of the antimonials 1–9 indicates their efficaciousness as compared with the standard antimonial drug used. The significant activity of complex 1 assumes that greater multitude of interactions is the cause of enhanced antileishmanial activity. Cytotoxicity results showed that these antimonials are highly active even at low concentrations and are biocompatible with human macrophages, making them promising drug candidates for further investigations in this field.